Staphylococcus aureus and topical fusidic acid use: results of a clinical audit on antimicrobial resistance
International Journal of Dermatology, 02/27/2013Heng YK et al.
Several studies have linked trends in prescribing medication and topical use of fusidic acid (FA) to development of resistance. However, few case–control studies have evaluated risk factors for developing FA resistance in S. aureus. Previous recent topical FA use correlated positively with FA resistance in S. aureus. Prescribing physicians must be vigilant of the rise of FA resistance and its resultant problems and prescribe topical FA discerningly.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.